Ignite Creation Date:
2024-05-06 @ 3:00 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02170090
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-05
First Post:
2014-06-18
Brief Title:
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization:
Universitätsklinikum Hamburg-Eppendorf
Organization Data
Organization:
Universitätsklinikum Hamburg-Eppendorf
Class:
OTHER
Study ID:
ACTICCA-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dutch Cancer Society | OTHER |
| Deutsche Krebshilfe eV Bonn Germany | OTHER |
| Cancer Research UK | OTHER |
| Australasian Gastro-Intestinal Trials Group | NETWORK |